Verified peer comparison
NovoCure vs Vaxcyte Financial Comparison
Direct answer
NovoCure and Vaxcyte are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- NovoCure Revenue
- 655,353,000 USD
- Vaxcyte Revenue
- 0 USD
- NovoCure Operating income
- -153,800,000 USD
- Vaxcyte Operating income
- -923,675,000 USD